About BELKIN Vision
BELKIN Vision is a company based in Yavne (Israel) founded in 2013 was acquired by Alcon in July 2024. BELKIN Vision has raised $14.75 million across 5 funding rounds from investors including Alcon, Santen Pharmaceuticals and European Union. BELKIN Vision offers products and services including DSLT and Hydrus Microstent. BELKIN Vision operates in a competitive market with competitors including ViaLase, ELIOS Vision, Radiance Therapeutics and EyeLight, among others.
- Headquarter Yavne, Israel
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Alcon Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BELKIN Vision
BELKIN Vision offers a comprehensive portfolio of products and services, including DSLT and Hydrus Microstent.
Delivers laser pulses to treat glaucoma and lower intraocular pressure.
Improves aqueous outflow in glaucoma patients for pressure reduction.
People of BELKIN Vision
Unlock access to complete
Unlock access to complete
Funding Insights of BELKIN Vision
BELKIN Vision has successfully raised a total of $14.75M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $2.84 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BELKIN Vision
BELKIN Vision has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Alcon, Santen Pharmaceuticals and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Limited information is provided about Rimonci's activities.
|
Locked | Locked | Locked | |
|
ZIG Ventures is focused on healthcare innovation investments.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for BELKIN Vision
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BELKIN Vision
Investment portfolio details for BELKIN Vision
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BELKIN Vision
Detailed financials for BELKIN Vision
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Belkin Vision Comparisons
Peer comparison for BELKIN Vision
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BELKIN Vision
BELKIN Vision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ViaLase, ELIOS Vision, Radiance Therapeutics and EyeLight, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Image-guided femtosecond laser devices for glaucoma treatments are developed.
|
|
| Locked | Locked | Locked |
Excimer laser technology is applied to develop glaucoma therapy devices.
|
|
| Locked | Locked | Locked |
Beta ophthalmic applicator for glaucoma surgery is developed.
|
|
| Locked | Locked | Locked |
Develops patented treatment methods for glaucoma.
|
Detailed competitors of BELKIN Vision
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Belkin Vision
Complete news archive for BELKIN Vision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BELKIN Vision
BELKIN Vision was founded in 2013 and raised its 1st funding round 3 years after it was founded.
BELKIN Vision is headquartered in Yavne, Israel. It is registered at Yavne, Central District, Israel.
BELKIN Vision is a funded company, having raised a total of $14.75M across 5 funding rounds to date.
BELKIN Vision was founded in 2013 in Yavne, Israel, where a laser device known as Vision DSLT is developed for glaucoma management. The device is designed for non-invasive, non-contact application, delivering laser energy to the limbus to improve intraocular fluid drainage and reduce pressure. Treatment is provided for open-angle and angle-closure glaucoma, with operations focused on medical device innovation in the ophthalmology sector. The companys domain is belkin-vision.com.
BELKIN Vision's top competitors include ViaLase, ELIOS Vision and Radiance Therapeutics.
BELKIN Vision offers DSLT and Hydrus Microstent.
BELKIN Vision has 8 investors. Key investors include Alcon, Santen Pharmaceuticals, European Union, BioLight, and Zicom Group.